ENTITY CLASS
Innate-immunity and inflammation peptides
Host-defense and immune-signaling peptides discussed without translating laboratory activity into treatment claims.
CONNECTED RECORDS
Innate-immunity and inflammation peptides: evidence by entity.
Peptide fragmentHuman evidence 1/5
KPV
KPV has a plausible anti-inflammatory research story in cells and animals, but that evidence has not established a safe or effective human drug product.
Open evidence recordNative peptideHuman evidence 1/5
LL-37
LL-37 is an important endogenous host-defense peptide, but complex pro-inflammatory, anti-inflammatory, antimicrobial, and cytotoxic actions make simple immune-support claims misleading.
Open evidence recordSynthetic peptideHuman evidence 3/5
Thymosin Alpha-1
Thymosin alpha-1 has more human research than many wellness-market peptides, yet the evidence remains indication-specific and does not amount to U.S. approval or a general immune-boosting claim.
Open evidence record